Literature DB >> 24845415

Distinct peritoneal fluid ghrelin and leptin in infertile women with endometriosis and their correlation with interleukin-6 and vascular endothelial growth factor.

Neha Rathore1, Alka Kriplani, Raj Kumar Yadav, Urja Jaiswal, Ritesh Netam.   

Abstract

OBJECTIVE: The objective of the present study was to evaluate the levels of leptin, ghrelin, interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) in peritoneal fluid in patients with endometriosis and infertility, and study their correlation. DESIGN AND
SETTING: This cross-sectional study included women undergoing diagnostic and/or therapeutic laparoscopy for endometriosis with chief complaint of infertility and/or pain at a tertiary care hospital. Based upon laparoscopic and histopathological findings, patients were categorized as with endometriosis and no endometriosis. Of the 50 patients with infertility (age 23-41 years), 19 had endometriosis while 31 had no endometriosis. The markers were assessed using ELISA kits.
RESULTS: The median levels of leptin in patients with endometriosis (10.20 ng/mL) were higher (p = 0.04) and median levels of ghrelin in patients with endometriosis (150.4 pg/mL) were lower (p = 0.037) versus patients with no endometriosis (5.07 ng/mL and 229.6 pg/mL, respectively). The median levels of IL-6 and VEGF in patients with endometriosis were not different between the groups. The correlation analyses showed that leptin levels and IL-6 were positively correlated (p = 0.0001).
CONCLUSIONS: The results suggest that ghrelin and leptin might play a key role in pathophysiology of endometriosis, and leptin is associated with inflammation in endometriosis.

Entities:  

Keywords:  Endometriosis; VEGF; ghrelin; interleukin-6; leptin; peritoneal fluid

Mesh:

Substances:

Year:  2014        PMID: 24845415     DOI: 10.3109/09513590.2014.920318

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  5 in total

Review 1.  Endometriosis: where are we and where are we going?

Authors:  Alexis D Greene; Stephanie A Lang; Jessica A Kendziorski; Julie M Sroga-Rios; Thomas J Herzog; Katherine A Burns
Journal:  Reproduction       Date:  2016-05-10       Impact factor: 3.906

Review 2.  Endometriosis Malignant Transformation: Epigenetics as a Probable Mechanism in Ovarian Tumorigenesis.

Authors:  Jiaxing He; Weiqin Chang; Chunyang Feng; Manhua Cui; Tianmin Xu
Journal:  Int J Genomics       Date:  2018-03-27       Impact factor: 2.326

Review 3.  The Formidable yet Unresolved Interplay between Endometriosis and Obesity.

Authors:  Athanasios Pantelis; Nikolaos Machairiotis; Dimitris P Lapatsanis
Journal:  ScientificWorldJournal       Date:  2021-04-20

4.  Nonhormonal therapy for endometriosis: a randomized, placebo-controlled, pilot study of cabergoline versus norethindrone acetate.

Authors:  Amy D DiVasta; Catherine Stamoulis; Jenny Sadler Gallagher; Marc R Laufer; Raymond Anchan; Mark D Hornstein
Journal:  F S Rep       Date:  2021-07-24

5.  Length of Menstrual Cycle and Risk of Endometriosis: A Meta-Analysis of 11 Case-Control Studies.

Authors:  Ming Wei; Yanfei Cheng; Huaien Bu; Ye Zhao; Wenli Zhao
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.